Progesterone Receptor Negative Withdrawn Phase 2 Trials for Chlorpheniramine (DB01114)

IndicationStatusPhase
DBCOND0038639 (Progesterone Receptor Negative)Withdrawn2
clinicaltrials.gov IdentifierTitlePurposeDrugs